Scott Manski

Scott Manski practices at TGH Surgery Center at Morsani in Tampa, Florida.

Scott Manski's NPI, 1518320399, was assigned on March 30, 2016. Scott Manski graduated from University of Maryland School of Medicine - Baltimore in 2016. Scott Manski holds Florida license ME160920.

Scott Manski's primary practice is TGH Surgery Center at Morsani, at 13330 Usf Laurel Dr, Mdh 2nd Floor, Tampa, FL 33612. The practice phone is (813) 396-2376.

Scott Manski's primary practice is TGH Surgery Center at Morsani in Tampa, Florida. Scott Manski is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Scott Manski to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Scott Manski practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Scott Manski's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Scott Manski is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Scott Manski's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy and upper GI endoscopy among the conditions Scott Manski treats.

CMS data shows 287 Medicare services from Scott Manski across 8 procedure codes in 2024, for 199 Medicare patients. Medicare paid $32,464 for them.

CMS counts 199 Medicare patients who saw Scott Manski in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Scott Manski's median patient age at 50, with 47% women.

In 2024, Scott Manski wrote 348 Medicare Part D claims for 87 patients. CMS names the drug for 210 of them, across 12 drugs with 11 or more claims each, at $2,011,341 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

Scott Manski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Scott Manski as offering telehealth. CMS counts 58 procedures of colonoscopy by Scott Manski, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Scott Manski, published from 2019 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Constriction, Pathologic and Crohn Disease. Scott Manski has published most often in Inflamm Bowel Dis. Scott Manski's most frequent co-authors are Devang Patel, MD, Raina Shivashankar, MD and Brian J. Blair, DO.

CMS Open Payments shows 13 general payments to Scott Manski from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 89% of the total. Janssen Pharmaceuticals, Inc paid the most, $332.

Scott Manski graduated from University of Maryland School of Medicine - Baltimore in 2016.

Scott Manski is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.